8-K/AThe WireRoutine
Reg FD Disclosure · Company Update
Filed Mar 21, 2023 · 3y ago · Accession 0001193125-23-075736
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Enliven Therapeutics, Inc.
- Ticker
- ELVN
- CIK
- 1672619
- Form type
- 8-K/A
- Filing date
- Mar 21, 2023
- Report date
- Feb 23, 2023
- Document
- d415677d8ka.htm
- Size
- 936 KB